Featured Articles
Four Dividend-paying Gold Funds to Purchase as Shields from Crises
Paul Dykewicz | April 7, 2023
Four dividend-paying gold funds to purchase as shields from inflation and crises near and far. The four dividend-paying gold funds to buy for protection from catastrophes should serve as safe havens for investors seeking a proven hedge against inflation. BofA Global Research correctly predicted several weeks ago that the price of gold would top $2,000 per ounce. On April 5,…
Five Dividend-paying Gold Stocks to Buy After Big Bank Woes
Paul Dykewicz | March 29, 2023
Five dividend-paying gold stocks to buy after several big banks recently collapsed offer a hedge against growing risks. The five dividend-paying gold stocks to buy are poised to produce income and profits in the face of big bank woes worsened by weak risk controls. Gold is a tradition way for investors to reduce risk. Forecasters such as the BofA Global…
Four Stocks to Buy for Double-Digit-Percentage Dividend Hikes
Paul Dykewicz | March 24, 2023
Four stocks to buy for double-digit-percentage dividend hikes may interest investors eyeing protection from recent bank collapses and any others that may follow. The four stocks to buy for double-digit-percentage dividend hikes hold special appeal amid unsteady market reactions to the seizure of three large banks by U.S. regulators within the past two weeks and the Swiss government brokering UBS…
Double-Digit-Percentage Dividend Increases Tempt Investors
Paul Dykewicz | March 18, 2023
Double-digit-percentage dividend increases tempt investors when offered by stocks on the rise, particularly after three recent big bank failures. The double-digit-percentage dividend increases tantalize investors who seek both income and share-price appreciation. The bonus with these stocks is that each has growth prospects that should support the payouts and price-share increases that investors seek. The three big bank closures in…
Three Dividend-paying Pharmaceutical Funds to Buy in Wake of Big U.S. Bank Failure
Paul Dykewicz | March 10, 2023
Three dividend-paying pharmaceutical funds to buy for income are supported by products people need amid the uncertainty of the second-biggest U.S. bank failure, Russia's unrelenting war in Ukraine, inflation and recession risk. The three dividend-paying pharmaceutical funds to buy offer investors exposure to stocks of various sizes, including large-cap companies with market capitalizations of $10 billion and up, as well…